Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2014-12

AUTHORS

Z Kang, Y Yu, Y J Zhu, S Davis, R Walker, P S Meltzer, L J Helman, L Cao

ABSTRACT

Agents targeting the insulin-like growth factor-1 receptor (IGF1R) are in clinical development, but, despite some initial success of single agents in sarcoma, response rates are low with brief durations. Thus, it is important to identify markers predictive of response, to understand mechanisms of resistance, and to explore combination therapies. In this study, we found that, although associated with PAX3-FKHR translocation, increased IGF1R level is an independent prognostic marker for worse overall survival, particularly in patients with PAX3-FKHR-positive rhabdomyosarcoma (RMS). IGF1R antibody-resistant RMS cells were generated using an in vivo model. Expression analysis indicated that IGFBP2 is both the most affected gene in the insulin-like growth factor (IGF) signaling pathway and the most significantly downregulated gene in the resistant lines, indicating that there is a strong selection to repress IGFBP2 expression in tumor cells resistant to IGF1R antibody. IGFBP2 is inhibitory to IGF1R phosphorylation and its signaling. Similar to antibodies to IGF1/2 or IGF2, the addition of exogenous IGFBP2 potentiates the activity of IGF1R antibody against the RMS cells, and it reverses the resistance to IGF1R antibody. In contrast to IGF1R, lower expression of IGFBP2 is associated with poorer overall survival, consistent with its inhibitory activity found in this study. Finally, blocking downstream Protein kinase B (AKT) activation with Phosphatidylinositide 3-kinases (PI3K)- or mammalian target of rapamycin (mTOR)-specific inhibitors significantly sensitized the resistant cells to the IGF1R antibody. These findings show that constitutive IGFBP2 downregulation may represent a novel mechanism for acquired resistance to IGF1R therapeutic antibody in vivo and suggest various drug combinations to enhance antibody activity and to overcome resistance. More... »

PAGES

5697

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/onc.2013.509

DOI

http://dx.doi.org/10.1038/onc.2013.509

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1038771559

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/24292683


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aminopyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Monoclonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Down-Regulation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Gene Expression Regulation, Neoplastic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin-Like Growth Factor Binding Protein 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mice, SCID", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Molecular Targeted Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Morpholines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptor, IGF Type 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rhabdomyosarcoma", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Treatment Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Xenograft Model Antitumor Assays", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Leidos (United States)", 
          "id": "https://www.grid.ac/institutes/grid.419407.f", 
          "name": [
            "Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA", 
            "Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kang", 
        "givenName": "Z", 
        "id": "sg:person.01372570767.27", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372570767.27"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "Y", 
        "id": "sg:person.01026163521.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026163521.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Zhu", 
        "givenName": "Y J", 
        "id": "sg:person.0717132043.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717132043.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Davis", 
        "givenName": "S", 
        "id": "sg:person.0610556244.08", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610556244.08"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Walker", 
        "givenName": "R", 
        "id": "sg:person.0656671444.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656671444.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Meltzer", 
        "givenName": "P S", 
        "id": "sg:person.014371167277.07", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014371167277.07"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Helman", 
        "givenName": "L J", 
        "id": "sg:person.01051423553.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051423553.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center for Cancer Research", 
          "id": "https://www.grid.ac/institutes/grid.417768.b", 
          "name": [
            "Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cao", 
        "givenName": "L", 
        "id": "sg:person.01176244377.39", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176244377.39"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-10-0719", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000938548"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2009.172", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004567308", 
          "https://doi.org/10.1038/onc.2009.172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2009.172", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004567308", 
          "https://doi.org/10.1038/onc.2009.172"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14728222.12.5.589", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005969818"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1168", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006265436", 
          "https://doi.org/10.1038/nrc1168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1168", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006265436", 
          "https://doi.org/10.1038/nrc1168"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc3215", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007018896", 
          "https://doi.org/10.1038/nrc3215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2010.640", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007760714", 
          "https://doi.org/10.1038/onc.2010.640"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2353/ajpath.2009.080631", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007911026"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1209990", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008091156", 
          "https://doi.org/10.1038/sj.onc.1209990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.onc.1209990", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008091156", 
          "https://doi.org/10.1038/sj.onc.1209990"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-10-1093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011331562"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.cmet.2009.11.007", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015576745"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-10-0391", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017333065"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0014-5793(98)01011-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019584845"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-06-1344", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022521149"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14728222.9.4.753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022730187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14728222.9.4.753", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022730187"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70354-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024081956"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.30.4154", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024735891"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/er.2001-0033", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026981408"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-08-1712", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028116867"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602963", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028286826", 
          "https://doi.org/10.1038/sj.bjc.6602963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6602963", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028286826", 
          "https://doi.org/10.1038/sj.bjc.6602963"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2011.36.6799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029562773"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0609139104", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032533066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrd2359", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035189756", 
          "https://doi.org/10.1038/nrd2359"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbcan.2006.05.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035338781"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0900807106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036405470"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2010.34.0000", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037699110"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djs258", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041142348"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2008.21.1268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042403156"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/onc.2010.364", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043702913", 
          "https://doi.org/10.1038/onc.2010.364"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-10-0582", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046912671"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/sim.4780090710", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049435167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc2536", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050986935", 
          "https://doi.org/10.1038/nrc2536"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.23.6745", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052038484"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nature11183", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053677952", 
          "https://doi.org/10.1038/nature11183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.276.5316.1268", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062556793"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.20.3.833", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202804"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/en.2006-1335", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064248363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/endo-123-6-2827", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064261955"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/endo.137.11.8895319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064280537"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/endo.140.12.7169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064282808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2001.19.12.3091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074835662"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074963871", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077961417", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1078426342", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1083072626", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2014-12", 
    "datePublishedReg": "2014-12-01", 
    "description": "Agents targeting the insulin-like growth factor-1 receptor (IGF1R) are in clinical development, but, despite some initial success of single agents in sarcoma, response rates are low with brief durations. Thus, it is important to identify markers predictive of response, to understand mechanisms of resistance, and to explore combination therapies. In this study, we found that, although associated with PAX3-FKHR translocation, increased IGF1R level is an independent prognostic marker for worse overall survival, particularly in patients with PAX3-FKHR-positive rhabdomyosarcoma (RMS). IGF1R antibody-resistant RMS cells were generated using an in vivo model. Expression analysis indicated that IGFBP2 is both the most affected gene in the insulin-like growth factor (IGF) signaling pathway and the most significantly downregulated gene in the resistant lines, indicating that there is a strong selection to repress IGFBP2 expression in tumor cells resistant to IGF1R antibody. IGFBP2 is inhibitory to IGF1R phosphorylation and its signaling. Similar to antibodies to IGF1/2 or IGF2, the addition of exogenous IGFBP2 potentiates the activity of IGF1R antibody against the RMS cells, and it reverses the resistance to IGF1R antibody. In contrast to IGF1R, lower expression of IGFBP2 is associated with poorer overall survival, consistent with its inhibitory activity found in this study. Finally, blocking downstream Protein kinase B (AKT) activation with Phosphatidylinositide 3-kinases (PI3K)- or mammalian target of rapamycin (mTOR)-specific inhibitors significantly sensitized the resistant cells to the IGF1R antibody. These findings show that constitutive IGFBP2 downregulation may represent a novel mechanism for acquired resistance to IGF1R therapeutic antibody in vivo and suggest various drug combinations to enhance antibody activity and to overcome resistance. ", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/onc.2013.509", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.5246872", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2726515", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1097543", 
        "issn": [
          "0950-9232", 
          "1476-5594"
        ], 
        "name": "Oncogene", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "50", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "33"
      }
    ], 
    "name": "Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma", 
    "pagination": "5697", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "b8b0e2fe99ede50623eb3a0501eb3a8240d283d6905754eb8f34356ae5383109"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "24292683"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8711562"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/onc.2013.509"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1038771559"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/onc.2013.509", 
      "https://app.dimensions.ai/details/publication/pub.1038771559"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000372_0000000372/records_117123_00000002.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/onc2013509"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.509'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.509'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.509'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/onc.2013.509'


 

This table displays all metadata directly associated to this object as RDF triples.

345 TRIPLES      21 PREDICATES      93 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/onc.2013.509 schema:about N01251e198f2f4a07bcde27bf6006d5a0
2 N02f4f9836f4f4ce1b091885dfd98e2ad
3 N04481883ad014f74a7c58f7661432a3e
4 N26f78a73115e445bbd3b7197baf45d87
5 N33589487c981486290a5e490e349cd3a
6 N3889d649ef4c45ce9421eeccd1f6debf
7 N6de0e45454c64b058f936b23990f8a0f
8 N7046ac4c8e824ebf803a45a3bad333d5
9 N72f306ee1f3542a4a90dcb73855efe9b
10 N84382a91d8fd45348dc830ed9de3e9b9
11 N8608a3c4321c40d78193002aa0331368
12 N972783c2cce74478abfc1991c902bda8
13 Na0c94944adfc476fa1c222f42ff882ad
14 Na2ed171166474a59bd2366de15123ccf
15 Na89f8201f69d4b139c642b54a6815e8e
16 Nbd76a08a29c44efdbc1667bf5d9390bf
17 Nd518f39a04de4944b6da7f664125aeb5
18 Ndc0ef04740c34db3804a81b4e8f16d75
19 Nde3ea8cbeab14da1b207f99bff09dac7
20 Nfbe7e4f4fff34aa4874f088693133c54
21 anzsrc-for:11
22 anzsrc-for:1103
23 schema:author Ne923bbacd26448dea84d0e22cfdd291e
24 schema:citation sg:pub.10.1038/nature11183
25 sg:pub.10.1038/nrc1168
26 sg:pub.10.1038/nrc2536
27 sg:pub.10.1038/nrc3215
28 sg:pub.10.1038/nrd2359
29 sg:pub.10.1038/onc.2009.172
30 sg:pub.10.1038/onc.2010.364
31 sg:pub.10.1038/onc.2010.640
32 sg:pub.10.1038/sj.bjc.6602963
33 sg:pub.10.1038/sj.onc.1209990
34 https://app.dimensions.ai/details/publication/pub.1074963871
35 https://app.dimensions.ai/details/publication/pub.1077961417
36 https://app.dimensions.ai/details/publication/pub.1078426342
37 https://app.dimensions.ai/details/publication/pub.1083072626
38 https://doi.org/10.1002/sim.4780090710
39 https://doi.org/10.1016/j.bbcan.2006.05.003
40 https://doi.org/10.1016/j.cmet.2009.11.007
41 https://doi.org/10.1016/s0014-5793(98)01011-4
42 https://doi.org/10.1016/s1470-2045(09)70354-7
43 https://doi.org/10.1073/pnas.0609139104
44 https://doi.org/10.1073/pnas.0900807106
45 https://doi.org/10.1093/jnci/djs258
46 https://doi.org/10.1126/science.276.5316.1268
47 https://doi.org/10.1158/0008-5472.can-06-1344
48 https://doi.org/10.1158/0008-5472.can-08-1712
49 https://doi.org/10.1158/0008-5472.can-10-0391
50 https://doi.org/10.1158/0008-5472.can-10-0582
51 https://doi.org/10.1158/0008-5472.can-10-1093
52 https://doi.org/10.1158/1535-7163.mct-10-0719
53 https://doi.org/10.1200/jco.20.3.833
54 https://doi.org/10.1200/jco.2001.19.12.3091
55 https://doi.org/10.1200/jco.2008.21.1268
56 https://doi.org/10.1200/jco.2009.23.6745
57 https://doi.org/10.1200/jco.2010.30.4154
58 https://doi.org/10.1200/jco.2010.34.0000
59 https://doi.org/10.1200/jco.2011.36.6799
60 https://doi.org/10.1210/en.2006-1335
61 https://doi.org/10.1210/endo-123-6-2827
62 https://doi.org/10.1210/endo.137.11.8895319
63 https://doi.org/10.1210/endo.140.12.7169
64 https://doi.org/10.1210/er.2001-0033
65 https://doi.org/10.1517/14728222.12.5.589
66 https://doi.org/10.1517/14728222.9.4.753
67 https://doi.org/10.2353/ajpath.2009.080631
68 schema:datePublished 2014-12
69 schema:datePublishedReg 2014-12-01
70 schema:description Agents targeting the insulin-like growth factor-1 receptor (IGF1R) are in clinical development, but, despite some initial success of single agents in sarcoma, response rates are low with brief durations. Thus, it is important to identify markers predictive of response, to understand mechanisms of resistance, and to explore combination therapies. In this study, we found that, although associated with PAX3-FKHR translocation, increased IGF1R level is an independent prognostic marker for worse overall survival, particularly in patients with PAX3-FKHR-positive rhabdomyosarcoma (RMS). IGF1R antibody-resistant RMS cells were generated using an in vivo model. Expression analysis indicated that IGFBP2 is both the most affected gene in the insulin-like growth factor (IGF) signaling pathway and the most significantly downregulated gene in the resistant lines, indicating that there is a strong selection to repress IGFBP2 expression in tumor cells resistant to IGF1R antibody. IGFBP2 is inhibitory to IGF1R phosphorylation and its signaling. Similar to antibodies to IGF1/2 or IGF2, the addition of exogenous IGFBP2 potentiates the activity of IGF1R antibody against the RMS cells, and it reverses the resistance to IGF1R antibody. In contrast to IGF1R, lower expression of IGFBP2 is associated with poorer overall survival, consistent with its inhibitory activity found in this study. Finally, blocking downstream Protein kinase B (AKT) activation with Phosphatidylinositide 3-kinases (PI3K)- or mammalian target of rapamycin (mTOR)-specific inhibitors significantly sensitized the resistant cells to the IGF1R antibody. These findings show that constitutive IGFBP2 downregulation may represent a novel mechanism for acquired resistance to IGF1R therapeutic antibody in vivo and suggest various drug combinations to enhance antibody activity and to overcome resistance.
71 schema:genre research_article
72 schema:inLanguage en
73 schema:isAccessibleForFree false
74 schema:isPartOf N2e0a3e2d3655425b8b9958df25a5a189
75 Ne932836906f14195bcf1aff466d3a8d9
76 sg:journal.1097543
77 schema:name Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma
78 schema:pagination 5697
79 schema:productId N1fa18846aa05437ebe1bbf27f3bb7801
80 N2026c64f2d874b789284813cd91e2f1e
81 Nd60927ca2ea246f9bd6793ec4b70c3ac
82 Nf2b1f415d50a42e7aa90b871e8293c4b
83 Nf9c558965e7249bd97a4544a42834b5b
84 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038771559
85 https://doi.org/10.1038/onc.2013.509
86 schema:sdDatePublished 2019-04-11T14:20
87 schema:sdLicense https://scigraph.springernature.com/explorer/license/
88 schema:sdPublisher N15098452863e4b9198112aa7f15ab929
89 schema:url https://www.nature.com/articles/onc2013509
90 sgo:license sg:explorer/license/
91 sgo:sdDataset articles
92 rdf:type schema:ScholarlyArticle
93 N01251e198f2f4a07bcde27bf6006d5a0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Mice, SCID
95 rdf:type schema:DefinedTerm
96 N02f4f9836f4f4ce1b091885dfd98e2ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Antibodies, Monoclonal
98 rdf:type schema:DefinedTerm
99 N04481883ad014f74a7c58f7661432a3e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Molecular Targeted Therapy
101 rdf:type schema:DefinedTerm
102 N07c2ec73f4f64801af51b3b22b048d5d rdf:first sg:person.0717132043.15
103 rdf:rest N20bebd07c81240b0a9dd71bc68e9b868
104 N15098452863e4b9198112aa7f15ab929 schema:name Springer Nature - SN SciGraph project
105 rdf:type schema:Organization
106 N1fa18846aa05437ebe1bbf27f3bb7801 schema:name doi
107 schema:value 10.1038/onc.2013.509
108 rdf:type schema:PropertyValue
109 N2026c64f2d874b789284813cd91e2f1e schema:name readcube_id
110 schema:value b8b0e2fe99ede50623eb3a0501eb3a8240d283d6905754eb8f34356ae5383109
111 rdf:type schema:PropertyValue
112 N20bebd07c81240b0a9dd71bc68e9b868 rdf:first sg:person.0610556244.08
113 rdf:rest N7a1e8a86d7b4426996270c0c0b2c826b
114 N26f78a73115e445bbd3b7197baf45d87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Down-Regulation
116 rdf:type schema:DefinedTerm
117 N28da6bde685446029e283429f00f1e6c rdf:first sg:person.01026163521.30
118 rdf:rest N07c2ec73f4f64801af51b3b22b048d5d
119 N2e0a3e2d3655425b8b9958df25a5a189 schema:issueNumber 50
120 rdf:type schema:PublicationIssue
121 N33589487c981486290a5e490e349cd3a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
122 schema:name Treatment Failure
123 rdf:type schema:DefinedTerm
124 N3889d649ef4c45ce9421eeccd1f6debf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Humans
126 rdf:type schema:DefinedTerm
127 N39e8195c7f294c16a5e1b0fbddfd5668 rdf:first sg:person.01051423553.47
128 rdf:rest Nb27ab5fbe58b4ecaac91632afa90b246
129 N6de0e45454c64b058f936b23990f8a0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Cell Line, Tumor
131 rdf:type schema:DefinedTerm
132 N7046ac4c8e824ebf803a45a3bad333d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Female
134 rdf:type schema:DefinedTerm
135 N72f306ee1f3542a4a90dcb73855efe9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Insulin-Like Growth Factor Binding Protein 2
137 rdf:type schema:DefinedTerm
138 N7a1e8a86d7b4426996270c0c0b2c826b rdf:first sg:person.0656671444.18
139 rdf:rest Na0f2e67175134bdcb1878ddde368063d
140 N84382a91d8fd45348dc830ed9de3e9b9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Animals
142 rdf:type schema:DefinedTerm
143 N8608a3c4321c40d78193002aa0331368 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Gene Expression Regulation, Neoplastic
145 rdf:type schema:DefinedTerm
146 N972783c2cce74478abfc1991c902bda8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Xenograft Model Antitumor Assays
148 rdf:type schema:DefinedTerm
149 Na0c94944adfc476fa1c222f42ff882ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Pyrimidines
151 rdf:type schema:DefinedTerm
152 Na0f2e67175134bdcb1878ddde368063d rdf:first sg:person.014371167277.07
153 rdf:rest N39e8195c7f294c16a5e1b0fbddfd5668
154 Na2ed171166474a59bd2366de15123ccf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
155 schema:name Aminopyridines
156 rdf:type schema:DefinedTerm
157 Na89f8201f69d4b139c642b54a6815e8e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Drug Resistance, Neoplasm
159 rdf:type schema:DefinedTerm
160 Nb27ab5fbe58b4ecaac91632afa90b246 rdf:first sg:person.01176244377.39
161 rdf:rest rdf:nil
162 Nbd76a08a29c44efdbc1667bf5d9390bf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Mice
164 rdf:type schema:DefinedTerm
165 Nd518f39a04de4944b6da7f664125aeb5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Antineoplastic Combined Chemotherapy Protocols
167 rdf:type schema:DefinedTerm
168 Nd60927ca2ea246f9bd6793ec4b70c3ac schema:name pubmed_id
169 schema:value 24292683
170 rdf:type schema:PropertyValue
171 Ndc0ef04740c34db3804a81b4e8f16d75 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
172 schema:name Receptor, IGF Type 1
173 rdf:type schema:DefinedTerm
174 Nde3ea8cbeab14da1b207f99bff09dac7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
175 schema:name Morpholines
176 rdf:type schema:DefinedTerm
177 Ne923bbacd26448dea84d0e22cfdd291e rdf:first sg:person.01372570767.27
178 rdf:rest N28da6bde685446029e283429f00f1e6c
179 Ne932836906f14195bcf1aff466d3a8d9 schema:volumeNumber 33
180 rdf:type schema:PublicationVolume
181 Nf2b1f415d50a42e7aa90b871e8293c4b schema:name dimensions_id
182 schema:value pub.1038771559
183 rdf:type schema:PropertyValue
184 Nf9c558965e7249bd97a4544a42834b5b schema:name nlm_unique_id
185 schema:value 8711562
186 rdf:type schema:PropertyValue
187 Nfbe7e4f4fff34aa4874f088693133c54 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
188 schema:name Rhabdomyosarcoma
189 rdf:type schema:DefinedTerm
190 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
191 schema:name Medical and Health Sciences
192 rdf:type schema:DefinedTerm
193 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
194 schema:name Clinical Sciences
195 rdf:type schema:DefinedTerm
196 sg:grant.2726515 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2013.509
197 rdf:type schema:MonetaryGrant
198 sg:grant.5246872 http://pending.schema.org/fundedItem sg:pub.10.1038/onc.2013.509
199 rdf:type schema:MonetaryGrant
200 sg:journal.1097543 schema:issn 0950-9232
201 1476-5594
202 schema:name Oncogene
203 rdf:type schema:Periodical
204 sg:person.01026163521.30 schema:affiliation https://www.grid.ac/institutes/grid.417768.b
205 schema:familyName Yu
206 schema:givenName Y
207 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026163521.30
208 rdf:type schema:Person
209 sg:person.01051423553.47 schema:affiliation https://www.grid.ac/institutes/grid.417768.b
210 schema:familyName Helman
211 schema:givenName L J
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01051423553.47
213 rdf:type schema:Person
214 sg:person.01176244377.39 schema:affiliation https://www.grid.ac/institutes/grid.417768.b
215 schema:familyName Cao
216 schema:givenName L
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01176244377.39
218 rdf:type schema:Person
219 sg:person.01372570767.27 schema:affiliation https://www.grid.ac/institutes/grid.419407.f
220 schema:familyName Kang
221 schema:givenName Z
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01372570767.27
223 rdf:type schema:Person
224 sg:person.014371167277.07 schema:affiliation https://www.grid.ac/institutes/grid.417768.b
225 schema:familyName Meltzer
226 schema:givenName P S
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014371167277.07
228 rdf:type schema:Person
229 sg:person.0610556244.08 schema:affiliation https://www.grid.ac/institutes/grid.417768.b
230 schema:familyName Davis
231 schema:givenName S
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0610556244.08
233 rdf:type schema:Person
234 sg:person.0656671444.18 schema:affiliation https://www.grid.ac/institutes/grid.417768.b
235 schema:familyName Walker
236 schema:givenName R
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0656671444.18
238 rdf:type schema:Person
239 sg:person.0717132043.15 schema:affiliation https://www.grid.ac/institutes/grid.417768.b
240 schema:familyName Zhu
241 schema:givenName Y J
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717132043.15
243 rdf:type schema:Person
244 sg:pub.10.1038/nature11183 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053677952
245 https://doi.org/10.1038/nature11183
246 rdf:type schema:CreativeWork
247 sg:pub.10.1038/nrc1168 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006265436
248 https://doi.org/10.1038/nrc1168
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/nrc2536 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050986935
251 https://doi.org/10.1038/nrc2536
252 rdf:type schema:CreativeWork
253 sg:pub.10.1038/nrc3215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007018896
254 https://doi.org/10.1038/nrc3215
255 rdf:type schema:CreativeWork
256 sg:pub.10.1038/nrd2359 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035189756
257 https://doi.org/10.1038/nrd2359
258 rdf:type schema:CreativeWork
259 sg:pub.10.1038/onc.2009.172 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004567308
260 https://doi.org/10.1038/onc.2009.172
261 rdf:type schema:CreativeWork
262 sg:pub.10.1038/onc.2010.364 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043702913
263 https://doi.org/10.1038/onc.2010.364
264 rdf:type schema:CreativeWork
265 sg:pub.10.1038/onc.2010.640 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007760714
266 https://doi.org/10.1038/onc.2010.640
267 rdf:type schema:CreativeWork
268 sg:pub.10.1038/sj.bjc.6602963 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028286826
269 https://doi.org/10.1038/sj.bjc.6602963
270 rdf:type schema:CreativeWork
271 sg:pub.10.1038/sj.onc.1209990 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008091156
272 https://doi.org/10.1038/sj.onc.1209990
273 rdf:type schema:CreativeWork
274 https://app.dimensions.ai/details/publication/pub.1074963871 schema:CreativeWork
275 https://app.dimensions.ai/details/publication/pub.1077961417 schema:CreativeWork
276 https://app.dimensions.ai/details/publication/pub.1078426342 schema:CreativeWork
277 https://app.dimensions.ai/details/publication/pub.1083072626 schema:CreativeWork
278 https://doi.org/10.1002/sim.4780090710 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049435167
279 rdf:type schema:CreativeWork
280 https://doi.org/10.1016/j.bbcan.2006.05.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035338781
281 rdf:type schema:CreativeWork
282 https://doi.org/10.1016/j.cmet.2009.11.007 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015576745
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1016/s0014-5793(98)01011-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019584845
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/s1470-2045(09)70354-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024081956
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1073/pnas.0609139104 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032533066
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1073/pnas.0900807106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036405470
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1093/jnci/djs258 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041142348
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1126/science.276.5316.1268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062556793
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1158/0008-5472.can-06-1344 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022521149
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1158/0008-5472.can-08-1712 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028116867
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1158/0008-5472.can-10-0391 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017333065
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1158/0008-5472.can-10-0582 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046912671
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1158/0008-5472.can-10-1093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011331562
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1158/1535-7163.mct-10-0719 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000938548
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1200/jco.20.3.833 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202804
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1200/jco.2001.19.12.3091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074835662
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1200/jco.2008.21.1268 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042403156
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1200/jco.2009.23.6745 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052038484
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1200/jco.2010.30.4154 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024735891
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1200/jco.2010.34.0000 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037699110
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1200/jco.2011.36.6799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029562773
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1210/en.2006-1335 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064248363
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1210/endo-123-6-2827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064261955
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1210/endo.137.11.8895319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064280537
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1210/endo.140.12.7169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064282808
329 rdf:type schema:CreativeWork
330 https://doi.org/10.1210/er.2001-0033 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026981408
331 rdf:type schema:CreativeWork
332 https://doi.org/10.1517/14728222.12.5.589 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005969818
333 rdf:type schema:CreativeWork
334 https://doi.org/10.1517/14728222.9.4.753 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022730187
335 rdf:type schema:CreativeWork
336 https://doi.org/10.2353/ajpath.2009.080631 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007911026
337 rdf:type schema:CreativeWork
338 https://www.grid.ac/institutes/grid.417768.b schema:alternateName Center for Cancer Research
339 schema:name Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
340 Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
341 rdf:type schema:Organization
342 https://www.grid.ac/institutes/grid.419407.f schema:alternateName Leidos (United States)
343 schema:name Cancer Research Technology Program, Leidos Biomedical Research, Inc., Frederick, MD, USA
344 Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
345 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...